BCL2 and cancer: Studies have shown that EGCG effectively induces apoptosis in various cancer cell types, including those associated with nasopharyngeal, breast, prostate, liver, bladder, and ovarian cancers, primarily through the modulation of Bcl-2 family proteins and the generation of reactive oxygen species (ROS) [78].